ArticleJournal of cellular and molecular medicine2020

Bromodomain and extraterminal domain inhibitor enhances the antitumor effect of imatinib in gastrointestinal stromal tumours.

Jianfeng Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.